Satoshi S. Nishizuka, M.D., Ph.D.
Based on technologies and know-how developed at Iwate Medical University Institute for Biomedical Sciences, Quantdetect, Inc. was launched on April 1, 2021, with the intention of “implementing the research product”. Quantdetect provides assays that have been developed from our original technologies, leading to a safer and fulfilling future.
|Company Name||Quantdetect, Inc.|
TOKYO SANKEI Bldg 27F 1-7-2 Chiyoda, Tokyo 100-0004, Japan
1-7-35 Chuo-dori, Morioka-shi, Iwate 020-0021 Core Field Morioka 1-3rd floor
L1 Advanced Science and Technology Institute of Iwate, 2-4-26
|Founder & CEO||Satoshi S. Nishizuka|
|Capital||19.918 million JPY|